Valtorcitabine - Combination Drug Therapy for Chronic Hepatitis B

 
Key Data:
Drug (brand/generic)
Valtorcitabine
Company/licensee
Idenix Pharmaceuticals/ Novartis Pharma
Therapy class
Nucleotide analogue
Product description
Oral L-deoxycytidine
Current indication
Chronic HBV infection
Market sector
Antiinfectives
Development status
Phase II



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development